Enhance Health, a health and diagnostics company delivering at-home monitoring and care workflows for chronic liver and kidney disease as well as urea cycle disorders, announced today the appointment of Marcus Osborne to its Board of Directors.
Marcus Osborne is a nationally recognized healthcare executive with deep experience driving consumer-centered transformation across payer, provider, retail, and global health systems. He currently serves as Vice President of Consumer Journey Management at Kaiser Permanente. Previously, he was CEO and Executive Chairman of RightMove, a company spun out of the Hospital for Special Surgery, and spent more than 15 years at Walmart in senior healthcare leadership roles, including Senior Vice President of Health Transformation, where he helped launch Walmart Health and expand access and affordability across the U.S. healthcare system.
“Marcus brings a rare combination of strategic vision, operational rigor, and a deep commitment to improving healthcare access and outcomes,” said Matt Leming of Enhance Health. “His leadership across some of the most complex and influential healthcare organizations in the world will be invaluable as we continue to scale our platform and impact.”
Enhance Health is redefining how chronic disease is monitored and managed by moving beyond episodic diagnostics to a continuous, data-driven health intelligence platform. The company’s approach is designed to deliver ongoing insights that enable earlier detection of health changes, more proactive intervention, and better long-term outcomes for patients and providers alike. By integrating advanced monitoring technologies with actionable analytics, Enhance Health supports a more personalized, preventive, and responsive model of care—one that aligns patients, clinicians, and health systems around sustained health rather than reactive treatment.
For more information, visit enhancehealthinc.com
About VIC Tech
Enhance Health is part of the portfolio of VIC Tech, a venture studio focused on creating companies from innovative academic research. Enhance's Breeze is the third device from a VIC Tech portfolio company to receive Breakthrough Device Designation from the FDA, highlighting VIC’s consistent track record of advancing impactful health technologies toward clinical and commercial success.